nomifensine has been researched along with Syndrome in 3 studies
Nomifensine: An isoquinoline derivative that prevents dopamine reuptake into synaptosomes. The maleate was formerly used in the treatment of depression. It was withdrawn worldwide in 1986 due to the risk of acute hemolytic anemia with intravascular hemolysis resulting from its use. In some cases, renal failure also developed. (From Martindale, The Extra Pharmacopoeia, 30th ed, p266)
nomifensine : An N-methylated tetrahydroisoquinoline carrying phenyl and amino substituents at positions C-4 and C-8, respectively.
Syndrome: A characteristic symptom complex.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sandyk, R | 1 |
| Guliamov, MG | 1 |
| Cunha, UV | 1 |
3 other studies available for nomifensine and Syndrome
| Article | Year |
|---|---|
Nomifensine-induced orofacial dyskinesia and Sydenham's chorea.
Topics: Chorea; Dyskinesia, Drug-Induced; Facial Muscles; Female; Humans; Middle Aged; Mouth; Nomifensine; S | 1987 |
[Comparative evaluation of the therapeutic efficacy of the antidepressants adepren, linamiphen and emovit].
Topics: Adjustment Disorders; Adolescent; Adult; Aminoquinolines; Antidepressive Agents; Bipolar Disorder; D | 1986 |
Antidepressants: their uses in nonpsychiatric disorders of aging.
Topics: Affective Symptoms; Aged; Antidepressive Agents; Chronic Disease; Colonic Diseases, Functional; Depr | 1986 |